Increased activation of HDAC1/2/6 and Sp1 underlies therapeutic resistance and tumor growth in glioblastoma

BACKGROUND: Glioblastoma is associated with poor prognosis and high mortality. Although the use of first-line temozolomide can reduce tumor growth, therapy-induced stress drives stem cells out of quiescence, leading to chemoresistance and glioblastoma recurrence. The specificity protein 1 (Sp1) tran...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Autores principales: Yang, Wen-Bin, Hsu, Che-Chia, Hsu, Tsung-I, Liou, Jing-Ping, Chang, Kwang-Yu, Chen, Pin-Yuan, Liu, Jr-Jiun, Yang, Shung-Tai, Wang, Jia-Yi, Yeh, Shiu-Hwa, Chen, Ruei-Ming, Chang, Wen-Chang, Chuang, Jian-Ying
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2020
Materias:
Basic and Translational Investigations
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7566541/
https://ncbi.nlm.nih.gov/pubmed/32328646
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa103
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares